Large [qnco]    
Scale [medd]    
Long-term Follow-up [hlca]    
studies [mnob]    
Japanese [popg]    
patient [podg]    
Non-alcoholic Fatty Liver Disease [dsyn]    
Onset [qlco]    
Hepatocellular carcinoma [neop]    
Object [inpr]    
Aim [idcn]    
studies [mnob]    
To [qlco]    
Incidence [qnco]    
Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
To [qlco]    
Utilities [orgt]    
Two [qnco]    
Non-invasive [ftcn]    
Predictability [qlco]    
procedures [inpr]    
Fibrosis, Liver [dsyn]    
Platelet [cell]    
Ratio [qnco]    
Index [inpr]    
Score [qnco]    
include [ftcn]    
Following [tmco]    
Three [qnco]    
Variability [qlco]    
Body Mass Index [diap]    
Ratio [qnco]    
Diabetes [dsyn]    
Predictability [idcn]    
Hepatocellular carcinoma [neop]    
Large [qnco]    
Population [qnco]    
Japanese [popg]    
patient [podg]    
Non-alcoholic Fatty Liver Disease [dsyn]    
Method [inpr]    
This [euka]    
Retrospective Cohort Study [resa]    
Conduct [inbe]    
Study Subject [grup]    
include [ftcn]    
patient [podg]    
Non-alcoholic Fatty Liver Disease [dsyn]    
diagnose [fndg]    
Ultrasonography [diap]    
median [spco]    
Follow-up [fndg]    
period [tmco]    
5 6 [fndg]    
year [tmco]    
Primary Endpoint [irda]    
Onset [qlco]    
Hepatocellular carcinoma [neop]    
Evaluable [ftcn]    
Perform [ftcn]    
Using [ftcn]    
methodology [inpr]    
Proportion [qlco]    
Hazard [qlco]    
Analysis [lbpr]    
Result [ftcn]    
New [tmco]    
Case [ftcn]    
Hepatocellular carcinoma [neop]    
diagnose [fndg]    
studies [mnob]    
Cumulative [qlco]    
Rate [acty]    
Non-alcoholic Fatty Liver Disease [dsyn]    
Relate [orch]    
Hepatocellular carcinoma [neop]    
year [tmco]    
year [tmco]    
year [tmco]    
Annual [tmco]    
Rate [acty]    
New [tmco]    
Hepatocellular carcinoma [neop]    
Multivariate Analysis [qnco]    
Identifiable [qlco]    
serum AST [lbpr]    
Level [qlco]    
/40 [tmco]    
IU/L [qnco]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
+2 [qnco]    
Platelet Count [lbpr]    
<3 [qnco]    
mU/L [qnco]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
+2 [qnco]    
23 [qnco]    
Age [orga]    
year [tmco]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
1+ [qnco]    
Diabetes [dsyn]    
Hazard Ratio [qnco]    
<3 [qnco]    
Confidence Interval [qnco]    
1+ [qnco]    
Independence [idcn]    
Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
+2 [qnco]    
consider [idcn]    
To [qlco]    
Significance [qnco]    
Fibrosis [patf]    
Equivalent [qlco]    
Nonalcoholic steatohepatitis [dsyn]    
Stage 3 [inpr]    
Cumulative [qlco]    
Rate [acty]    
Hepatocellular carcinoma [neop]    
High [qlco]    
Group [idcn]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
69 [inpr]    
Contrast [qlco]    
Score [qnco]    
<3 [qnco]    
patient [podg]    
consider [idcn]    
To [qlco]    
Advance [qlco]    
Fibrosis [patf]    
Nonalcoholic steatohepatitis [dsyn]    
Stage 3 [inpr]    
Significance [qnco]    
Associate [menp]    
Score [qnco]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
Observation [ftcn]    
Hazard Ratio [qnco]    
1+ [qnco]    
Confidence Interval [qnco]    
/40 [tmco]    
Conclusion [idcn]    
This [euka]    
Retrospective Studies [resa]    
Annual [tmco]    
Incidence Rate [qnco]    
Hepatocellular carcinoma [neop]    
Japanese [popg]    
Non-alcoholic Fatty Liver Disease [dsyn]    
patient [podg]    
low [qlco]    
Elderly [popg]    
Non-alcoholic Fatty Liver Disease [dsyn]    
patient [podg]    
Diabetes [dsyn]    
elevated ast [fndg]    
Serum [bdsu]    
Thrombocytopenia [fndg]    
Suggest [idcn]    
To [qlco]    
Associated [qlco]    
Advance [qlco]    
Fibrosis, Liver [dsyn]    
monitor [hlca]    
Follow-up [fndg]    
include [ftcn]    
Using [ftcn]    
Ensure [food]    
Early Diagnosis [diap]    
treatment [ftcn]    
Hepatocellular carcinoma [neop]    
